Champions Oncology, Inc.: director Joel Ackerman exercised 69,794 shares

What happened Joel Ackerman, a director, exercised options for 69,794 shares at $1.60 per share on Oct 15, 2026, for $111,670 and the filing shows a contemporaneous disposition of 69,794 derivative securities at $1.60 for $111,670.

Key details

• Transaction date: Oct 15, 2026; price: $1.60 per share (transaction code M for both exercise and derivative disposition).
• Report filed on Oct 16, 2026 covering the Oct 15, 2026 transaction.
• Shares owned after the transaction: not reported in the provided excerpt.
• Footnote F1: "The Options vest and are exercisable over a twelve month period, with vesting to occur on Jan 31, 2017, Apr 30, 2017, Jul 31, 2017 and Oct 31, 2017, respectively."

Why it may matter

• The filing shows an exercise of options and a simultaneous disposition of the resulting derivative securities for the same number of shares, which indicates the shares were disposed of at once according to the reported entries.
• A filing does not show why the insider traded or why the company acted.